SCHEMBL5789671

SCHEMBL5789671

c1cnc2c(c1)ccc1nccnc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.73
CCR1 P32246 4/20 0.73
CCR8 P51685 4/20 0.73
CCR5 P51681 3/20 0.73
KDM4E B2RXH2 3/20 0.73
MAPT P10636 3/20 0.73
HTT P42858 3/20 0.73
CYP3A4 P08684 2/20 0.73
MMP2 P08253 2/20 0.73
TSHR P16473 2/20 0.73
SMN1; SMN2 Q16637 2/20 0.73
TDP1 Q9NUW8 2/20 0.73
GMNN O75496 1/20 0.73
TP53 P04637 1/20 0.73
HSP90AA1 P07900 1/20 0.73
CYP2D6 P10635 1/20 0.73
MMP9 P14780 1/20 0.73
ALOX15 P16050 1/20 0.73
NFKB1 P19838 1/20 0.73
MMP8 P22894 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31418346 1.00 LMNA (0.73) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL5192184 0.86 LMNA (0.73) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL29354015 0.85 CCR1 (1.00) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL29367277 0.85 CCR1 (1.00) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL8845760 0.85 CCR1 (1.00) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL8312 0.85 CCR1 (1.00) LMNACCR1CCR8CCR5KDM4E
SCHEMBL13859945 0.84 LMNA (0.58) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL9343811 0.83 KDM4E (0.84) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL22982126 0.83 CCR1 (0.94) LMNACCR1CCR8CCR5KDM4E
Phenanthroline SCHEMBL21060516 0.83 CCR1 (0.94) LMNACCR1CCR8CCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4965265-A PLANT DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1990-10-23 US claimed
EP-0341476-A2 4-Aza-1,10-phenanthroline derivates BAYER AG (DE) 1989-11-15 EP claimed
JP-1319483-A None JP disclosed
US-20230242556-A1 NOVEL METHOD FOR MANUFACTURING DEUTERATED BORON COMPOUND SFC CO., LTD. (KR) 2023-08-03 US disclosed
CN-114280200-B Method for simultaneously detecting three component contents of praziquantel, clofenacin and milbexime 上海汉维生物医药科技有限公司 2023-07-07 CN disclosed
US-11672172-B2 Heterocyclic compound comprising aromatic amine group and organic light-emitting diode including the same SFC CO., LTD. (KR) 2023-06-06 US disclosed
CN-114280200-A Method for simultaneously detecting content of three components of praziquantel, clofenacin and milbemycin oxime 上海汉维生物医药科技有限公司 2022-04-05 CN disclosed
US-10014479-B2 Organic light-emitting diode with high efficiency and long lifetime SFC CO., LTD. (KR) 2018-07-03 US disclosed
US-9947877-B2 Organic light emitting display device LG DISPLAY CO., LTD. (KR) 2018-04-17 US disclosed
US-20170222160-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-08-03 US disclosed
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-07-20 US disclosed
US-4965265-A PLANT DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1990-10-23 US disclosed
JP-H01319483-A 4-AZA-1,10-PHENANTHROLINE DERIVATIVE BAYER AG 1989-12-25 JP disclosed
EP-0341476-A2 4-Aza-1,10-phenanthroline derivates BAYER AG (DE) 1989-11-15 EP disclosed
EP-0341476-A2 4-Aza-1,10-phenanthroline derivates BAYER AG (DE) 1989-11-15 EP disclosed
EP-0341476-A2 4-Aza-1,10-phenanthroline derivates BAYER AG (DE) 1989-11-15 EP disclosed
EP-0311010-A2 Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1989-04-12 EP disclosed
US-4357470-A ANTIBACTERIAL AGENT TAISHO PHARMACEUTICAL CO., LTD. (JP) 1982-11-02 US disclosed
US-4190581-A Novel penicillin derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 1980-02-26 US disclosed
US-3899490-A Hexahydro pyrazinoquinolines PFIZER 1975-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170222160-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME ALDH1A2, LAGE3, AOX1 LMNA 1011/4885CCR1 3733/4885CCR8 4116/4885
US-20230242556-A1 NOVEL METHOD FOR MANUFACTURING DEUTERATED BORON COMPOUND BCL6B, BRD7, DBF4 LMNA 1747/4885CCR1 4616/4885CCR8 4085/4885
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME HARS1, ALDH1A2, ALDH1A3 LMNA 3353/4885CCR1 2408/4885CCR8 3843/4885
US-10014479-B2 Organic light-emitting diode with high efficiency and long lifetime EML4, CRY2, ESR1 LMNA 877/4885CCR1 4600/4885CCR8 4512/4885
US-11672172-B2 Heterocyclic compound comprising aromatic amine group and organic light-emitting diode including the same DDC, TYR, AOC2 LMNA 2443/4885CCR1 3930/4885CCR8 3276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.